Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126352371 | 12635237 | 1 | I | 20160802 | 20160808 | 20160808 | EXP | TR-GILEAD-2016-0226660 | GILEAD | OZCAN G, ET AL.. ADVERSE DRUG REACTION REPORTING PATTERN IN TURKEY: ANALYSIS OF THE NATIONAL DATABASE IN THE CONTEXT OF THE FIRST PHARMACOVIGILANCE LEGISLATION. DRUGS - REAL WORLD OUTCOMES. 2016;3(1):33-43 | 0.00 | A | F | Y | 0.00000 | 20160808 | MD | TR | TR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126352371 | 12635237 | 1 | PS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | U | U | 21356 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126352371 | 12635237 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126352371 | 12635237 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126352371 | 12635237 | Foetal death | |
| 126352371 | 12635237 | Maternal exposure during pregnancy | |
| 126352371 | 12635237 | Placental disorder | |
| 126352371 | 12635237 | Premature baby |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |